Effects of testosterone on glycaemic control and other Cardiovascular Risk factors in Hypogonadal Men with uncontrolled Type 2 Diabetes: A randomized double – blinded placebo controlled add on trial using depot testosterone undecanoate.

Status: Suspended

Phase of Trial: Phase IV

Latest Information Update: 08 Jun 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Testosterone undecanoate (Primary)
Indications Hypogonadism; Type 2 diabetes mellitus
Focus Pharmacodynamics

Most Recent Events

02 Jul 2015 Planned End Date changed from 15 Oct 2014 to 15 Jan 2015 as reported by United Kingdom Clinical Research Network record.
02 Jul 2015 Status changed from recruiting to suspended as reported by United Kingdom Clinical Research Network record.
08 Jan 2015 Accrual to date is 61% according to United Kingdom Clinical Research Network record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight